Dolby Laboratories (NYSE:DLB) SVP Shriram Revankar Sells 3,000 Shares

Dolby Laboratories (NYSE:DLB) SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $54.90, for a total transaction of $164,700.00. Following the transaction, the senior vice president directly owned 80,603 shares in the company, valued at $4,425,104.70. This trade represents a 3.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Dolby Laboratories Price Performance

Dolby Laboratories stock traded down $1.05 during trading hours on Tuesday, reaching $53.32. The company had a trading volume of 832,428 shares, compared to its average volume of 761,660. The company has a 50-day moving average price of $60.88 and a 200 day moving average price of $63.67. Dolby Laboratories has a 12-month low of $53.20 and a 12-month high of $77.14. The firm has a market cap of $5.04 billion, a price-to-earnings ratio of 21.08 and a beta of 0.86.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business had revenue of $395.63 million during the quarter, compared to analysts’ expectations of $385.80 million. During the same quarter last year, the business posted $1.34 EPS. The business’s revenue was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, research analysts expect that Dolby Laboratories will post 3.22 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be paid a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a yield of 2.7%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 56.92%.

Institutional Trading of Dolby Laboratories

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Norges Bank purchased a new stake in Dolby Laboratories during the 4th quarter valued at about $54,966,000. AQR Capital Management LLC increased its holdings in Dolby Laboratories by 51.8% in the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after buying an additional 592,282 shares in the last quarter. First Trust Advisors LP increased its holdings in Dolby Laboratories by 19.9% in the 1st quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock worth $135,431,000 after buying an additional 374,405 shares in the last quarter. Alyeska Investment Group L.P. bought a new stake in Dolby Laboratories in the 4th quarter worth about $23,477,000. Finally, Voloridge Investment Management LLC increased its holdings in Dolby Laboratories by 2,017.9% in the 4th quarter. Voloridge Investment Management LLC now owns 325,499 shares of the electronics maker’s stock worth $20,904,000 after buying an additional 310,130 shares in the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price target on shares of Dolby Laboratories in a research note on Monday, April 27th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Rosenblatt Securities reissued a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research report on Friday, January 30th. Finally, Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $90.75.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.